EP3166976

BIRDIE BIOPHARMACEUTICALS
Application Number
EP15819519A
Filing Date
Jul 8, 2015
Status
Granted And Under Opposition
Jan 21, 2022
Grant Date
Feb 23, 2022
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP3166976B1 was granted on Feb 23, 2022 by Birdie Biopharmaceuticals The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PATENT BOUTIQUENov 23, 2022ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2013043647
N/A
OppositionUS2017114137
N/A
OppositionWO2014012479
N/A
OppositionUS2002015715
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.